Martini-Klinik
Martini-Klinik is a Hamburg-based, UKE-affiliated specialty clinic focused exclusively on prostate cancer, performing more than 2,600 prostatectomies per year across the full diagnostic and treatment continuum for German and international patients.
- Company typePrivate
- Founded-
- HeadquartersHamburg, Germany
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Martini-Klinik does
Martini-Klinik am UKE GmbH is a privately licensed specialty clinic located on the campus of the University Medical Center Hamburg-Eppendorf (UKE) in Hamburg, Germany. It operates as a wholly-owned subsidiary of UKE and devotes its entire clinical capacity to the diagnosis and treatment of prostate cancer, offering the full disease continuum: fusion biopsy diagnostics, open and robotic-assisted radical prostatectomy (using both the da Vinci and Hugo RAS systems), brachytherapy (LDR permanent seeds and HDR temporary implantation), focal therapy, active surveillance, drug therapy, and salvage procedures including radioguided lymph node removal.
Care is delivered by a faculty of approximately 10 senior consultants who work side by side, combining subspecialized expertise with high surgical volume — more than 2,600 prostatectomies are performed annually against roughly 2,500 patient decisions for surgical removal, with the balance going to radiation (~200), focal therapy (~50) and active surveillance (~150). The clinic runs a continuous, pseudonymised outcome monitoring program across all past patients, publishing functional recovery metrics (90.3% post-surgical continence, 81.0% potency) and reporting a 98.5% patient recommendation rate.
The revenue model is professional services for medical treatment, billed to German private and statutory health insurers plus international patients. International acquisition is supported by a 15-language website, dedicated EU and non-EU phone lines, and UKE's International Office; international case examples include patients traveling from the Netherlands, Scandinavia, and the United States. Pricing is not publicly disclosed, and the clinic publishes no revenue figures, operating as a private German GmbH subsidiary without external fundraising. A separate senior faculty roster (professors Graefen, Heinzer, Haese, Steuber, Salomon, Thederan, Budäus, Tilki, Maurer, von Amsberg, Mandel, and Huland) indicates the depth of subspecialty bench strength behind the service line.
Martini-Klinik firmographics
Firmographics- Name
- Martini-Klinik
- Legal name
- Martini-Klinik am UKE GmbH
- Website
- https://martini-klinik.de
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Martini-Klinik is a Hamburg-based, UKE-affiliated specialty clinic focused exclusively on prostate cancer, performing more than 2,600 prostatectomies per year across the full diagnostic and treatment continuum for German and international patients.
- Ownership category
- akta.pro rank
Martini-Klinik industry classification
Industry- Product category
- Specialty Healthcare — Prostate Cancer Treatment
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Urologic Oncology (HLAKAOAB)
- akta.pro secondary industries
- General Urology (HLAKAOAA), Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD)
Keywords
Where Martini-Klinik is headquartered
LocationHeadquarters
- HQ city
- Hamburg
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Martini-Klinik business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
Revenue model
- Medical Treatment Services: Revenue generated from comprehensive prostate cancer diagnostic and treatment services including surgery, radiotherapy, brachytherapy, focal therapy, and active surveillance. Services provided to both privately insured and public health insurance patients.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Martini-Klinik product offering
Product offeringCore offering
Martini-Klinik is a highly specialized private clinic that exclusively diagnoses and treats prostate cancer. It offers the complete spectrum of prostate cancer care — diagnostics (fusion biopsy, spread determination), radical prostatectomy via conventional open or robotic-assisted (da Vinci, Hugo RAS) surgery, brachytherapy (LDR and HDR), focal therapy, active surveillance, drug therapy, salvage prostatectomy, and radioguided lymph node removal — delivered by a faculty of 10 senior consultants and supported by continuous outcome quality monitoring.
Product overview
The Martini-Klinik is a highly specialized private clinic focused exclusively on prostate cancer diagnosis and treatment. The clinic offers a comprehensive range of services organized around four main treatment strategies: surgical removal of the prostate (radical prostatectomy via open or robotic-assisted approaches using da Vinci and Hugo RAS systems), radiotherapy including brachytherapy (both LDR and HDR), focal therapy for targeted tumor treatment, and active surveillance for low-risk patients. Additional services include drug therapy for advanced cases, radioguided lymph node surgery, and telemedicine consultations. The clinic operates with a faculty system of 10 senior consultants and monitors outcomes for all patients to maintain quality metrics including 90.3% post-surgical continence and 81% potency rates.
Differentiator
Problem solved
Functional benefit
Products and services
- Prostate Cancer Diagnostics
Quantifiable outcome
- Post-surgical continence rate: 90.3%
- +3 more outcomes
Companies that use Martini-Klinik
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Martini-Klinik technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Martini-Klinik partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- University Medical Center Hamburg-Eppendorf (UKE)coreMartini-Klinik is a subsidiary of the University Medical Center Hamburg-Eppendorf (UKE). The clinic is located within the UKE campus and utilizes the hospital's infrastructure and resources. The IT department of UKE has access to data during maintenance. International patients are coordinated through UKE's International Office.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Martini-Klinik competitors and assessment
Company assessmentDirect peers
- The Prostate Centre: London-based private clinic specializing exclusively in prostate cancer diagnosis and treatment. Closely comparable single-disease specialist model serving both domestic and international patients.
- Institut Mutualiste Montsouris: Paris-based private hospital internationally renowned for high-volume robotic and open radical prostatectomy. Like Martini-Klinik, it operates as a high-volume prostate surgery destination with outcomes-driven reputation.
- Nuada Urology: Portuguese specialty urology and prostate clinic focused on minimally invasive and robotic surgery, comparable as a single-disease, outcomes-focused private specialist.
Broad incumbents
- Karolinska University Hospital: Nordic academic medical center with a high-volume urology and prostate cancer surgery program, comparable as a publicly affiliated specialty provider serving cross-border patients.
- Memorial Sloan Kettering Cancer Center: US specialty cancer center with a major urologic oncology service, comparable as a research-driven, outcomes-monitored destination for complex prostate cancer cases.
- Charité – Universitätsmedizin Berlin: Germany's largest university hospital with a high-volume urology department and prostate cancer program operating at scale within an academic medical center, broadly comparable in capability though not exclusively prostate-focused.
- Cleveland Clinic – Glickman Urological Institute: US-based high-volume urology program within a large academic health system, comparable in robotic prostatectomy throughput and outcomes benchmarking.
- Royal Marsden Hospital: UK specialist cancer hospital with a dedicated urological cancers unit, comparable as an outcomes-driven, multi-modality cancer center serving international patients.
- Heidelberg University Hospital (UKHD): Leading German university hospital with a strong urologic oncology program and robotic surgery platform, drawing both domestic and international prostate cancer patients.
Regional players
- Erasmus MC – University Medical Center Rotterdam: Dutch academic medical center with a strong urology and prostate cancer program, comparable in capability though primarily serving the Netherlands rather than competing directly in Hamburg's German catchment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Martini-Klinik social profiles
Digital presenceMartini-Klinik financial estimates
Financial estimateRevenue estimate
Valuation estimate
Martini-Klinik leadership team
Management profileNumber of profiles
Profiles12 records
Martini-Klinik funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Martini-Klinik M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Martini-Klinik
What does Martini-Klinik do?
Martini-Klinik is a highly specialized private clinic that exclusively diagnoses and treats prostate cancer. It offers the complete spectrum of prostate cancer care — diagnostics (fusion biopsy, spread determination), radical prostatectomy via conventional open or robotic-assisted (da Vinci, Hugo RAS) surgery, brachytherapy (LDR and HDR), focal therapy, active surveillance, drug therapy, salvage prostatectomy, and radioguided lymph node removal — delivered by a faculty of 10 senior consultants and supported by continuous outcome quality monitoring.
Is Martini-Klinik a public or private company?
Martini-Klinik is a private company. It is classified as state government owned and is currently operating.
When was Martini-Klinik founded?
Martini-Klinik was founded in -1. It employs 11 to 50 people.
Where is Martini-Klinik based?
Martini-Klinik is headquartered in Hamburg, Germany, in the Europe region.
How does Martini-Klinik make money?
One revenue line is on record: medical Treatment Services.
Who are Martini-Klinik's main competitors?
Direct peers on record are The Prostate Centre, Institut Mutualiste Montsouris and Nuada Urology. Broad incumbents are Karolinska University Hospital, Memorial Sloan Kettering Cancer Center, Charité – Universitätsmedizin Berlin, Cleveland Clinic – Glickman Urological Institute, Royal Marsden Hospital and Heidelberg University Hospital (UKHD). Erasmus MC – University Medical Center Rotterdam is listed as a regional player.
Does Martini-Klinik have an API?
No public API is recorded for Martini-Klinik.
What industry is Martini-Klinik in?
Martini-Klinik's product category is Specialty Healthcare — Prostate Cancer Treatment. Its primary akta.pro industry code is HLAKAOAB, Urologic Oncology, with a secondary code of HLAKAOAA, General Urology. Its NAICS code is 62231 and its SIC code is 8011.